The new pharmaceutical pricing reforms leave many controls in place, sparking questions on the objective of the changes. Here we push past the fog to see what's really going on
Foreign Direct Investment
- June 12, 2015
Which FTZ should I invest in and which sectors are off limits? Are the zones really more liberal towards foreign investment in practice? What are the administrative and approval procedures to set up a company?
June 10, 2015The new Foreign Investment Industrial Guidance Catalogue has opened up and closed off a number of key industries accessible to overseas investors. It may be the last version as China moves to further reform the FDI framework
June 10, 2015The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline
June 09, 2015The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline
June 09, 2015China issues a combined negative list for all four FTZs.
May 14, 2015Foreign investment catalogue revised to allow more foreign shareholding.
May 14, 2015Foreign investment catalogue revised to allow more foreign shareholding.
April 29, 2015Enterprises enjoy tax breaks for investment in Western China.
April 29, 2015The Measures are revised to follow changes in the List of Investment Projects Subject to Government Check and Approval, which relaxes foreign projects approval requirements.
April 16, 2015
